VoltaDexibu - Die OTC-Innovation in der Voltaren-Familie

Referenzen

1. Fachinformation VoltaDexibu Schmerztabletten 200 mg, Stand April 2024.
2. Dionne RA et al. “Enhanced analgesia and suppression of plasma ß-endorphin by the S (+)-isomer of ibuprofen.” Clinical Pharmacology & Therapeutics 63.6 (1998): 694-701.
3. Phleps, W. (2001). Overview on clinical data of dexibuprofen. Clinical rheumatology, 20, 15-21.
4. Evans, A.M., (2001). Comparative pharmacology of S (+)-ibuprofen and (RS)-ibuprofen. Clinical rheumatology, 20, pp.9-14.
5. Kaehler, S. T., Phleps, W., & Hesse, E. (2003). Dexibuprofen: pharmacology, therapeutic uses and safety. Inflammopharmacology, 11, 371-383.
6. Gliszczyńska, A., & Sánchez-López, E. (2021). Dexibuprofen therapeutic advances: Prodrugs and nanotechnological formulations. Pharmaceutics, 13(3), 414.